The report comes days after Trump named Elon Musk as a co-head of the incoming administration's government efficiency department
auto7 hours ago
Britain on Thursday launched a trial to assess the immune responses generated if doses of the Covid-19 vaccines from Pfizer Inc and AstraZeneca Plc are combined in a two-shot schedule
The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.
The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca’s, as well as vice versa, with intervals of 4 and 12 weeks.
Both the mRNA shot developed by Pfizer and Biontech and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine.
It is expected more vaccines will be added to the trial when they are approved and rolled out.
Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.
The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.
Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.
“We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,” he told reporters.
The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.
AstraZeneca’s shot is also being tested in combination with Russia’s Sputnik V vaccine, and British drugmaker’s research chief has said more studies on combining vaccines should be done.
The report comes days after Trump named Elon Musk as a co-head of the incoming administration's government efficiency department
auto7 hours ago
Easing oil prices helps lower transport costs in emirate
economy7 hours ago
Investor focus is now expected to quickly move to earnings expectations for 2025
finance7 hours ago
Realtor unveils its second project, coming up in Al Furjan
business7 hours ago
Lazzarini says within the UN, there is no other agency geared to provide the same activities
mena8 hours ago
Alleno, known for 'modern cuisine', on his go-to ingredient choices for a quick meal
lifestyle8 hours ago
'It became a symbol of the Dubai dream,' says culinary innovator Nouel Catis, who helped craft the Internet's most favourite dessert flavour
food8 hours ago
Ahead of the KT Events' DXB F&B Awards on November 27, jury member and chef and podcaster James Knight-Paccheco talks at length about his culinary journey
lifestyle8 hours ago